InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q2 2024

By InvestorPlace Earnings

ADVM stock results show that Adverum Biotechnologies beat analyst estimates for earnings per share the second quarter of 2024.

SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

IMNM Stock Earnings: Immunome Misses EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

IMNM stock results show that Immunome missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

TXMD Stock Earnings: TherapeuticsMD Reported Results for Q2 2024

By InvestorPlace Earnings

TherapeuticsMD just reported results for the second quarter of 2024.

AEON Stock Earnings: AEON Biopharma Beats EPS for Q2 2024

By InvestorPlace Earnings

AEON stock results show that AEON Biopharma beat analyst estimates for earnings per share the second quarter of 2024.

Load More